SNDL (SNDL) Competitors

SNDL (NASDAQ:SNDL) and Vera Therapeutics (NASDAQ:VERA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, community ranking, dividends, earnings and risk.

Is SNDL or VERA more profitable?

Vera Therapeutics has a net margin of 0.00% compared to SNDL's net margin of -12.11%. SNDL's return on equity of -8.27% beat Vera Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-12.11%	-8.27%	-6.96%
Vera Therapeutics	N/A	-50.13%	-39.50%

Which has stronger earnings & valuation, SNDL or VERA?

Vera Therapeutics has lower revenue, but higher earnings than SNDL. Vera Therapeutics is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$927.61M	0.38	-$127.91M	-$0.29	-4.59
Vera Therapeutics	N/A	N/A	-$95.99M	-$3.00	-7.08

Which has more volatility and risk, SNDL or VERA?

SNDL has a beta of 3.68, suggesting that its share price is 268% more volatile than the S&P 500. Comparatively, Vera Therapeutics has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.

Do analysts rate SNDL or VERA?

SNDL currently has a consensus target price of $3.63, indicating a potential upside of 172.56%. Vera Therapeutics has a consensus target price of $63.33, indicating a potential upside of 198.18%. Given Vera Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Vera Therapeutics is more favorable than SNDL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Vera Therapeutics	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.10

Do institutionals and insiders hold more shares of SNDL or VERA?

99.2% of Vera Therapeutics shares are held by institutional investors. 16.3% of Vera Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Does the MarketBeat Community believe in SNDL or VERA?

SNDL received 98 more outperform votes than Vera Therapeutics when rated by MarketBeat users. Likewise, 71.94% of users gave SNDL an outperform vote while only 66.15% of users gave Vera Therapeutics an outperform vote.

Company	Underperform	Outperform
SNDL	Outperform Votes 141 71.94%	Underperform Votes 55 28.06%
Vera Therapeutics	Outperform Votes 43 66.15%	Underperform Votes 22 33.85%

Does the media prefer SNDL or VERA?

In the previous week, Vera Therapeutics had 11 more articles in the media than SNDL. MarketBeat recorded 14 mentions for Vera Therapeutics and 3 mentions for SNDL. SNDL's average media sentiment score of 1.49 beat Vera Therapeutics' score of 1.17 indicating that SNDL is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Vera Therapeutics	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

SNDL and Vera Therapeutics tied by winning 9 of the 18 factors compared between the two stocks.